2023
DOI: 10.1007/s00210-023-02631-1
|View full text |Cite
|
Sign up to set email alerts
|

A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 151 publications
0
2
0
Order By: Relevance
“…This strategy directly tackles genetic factors contributing to T2DM and has the potential not only to manage but also to potentially reverse the condition’s progression. However, thorough research and clinical trials are essential to fully understand its safety, efficacy, and long-term impacts [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…This strategy directly tackles genetic factors contributing to T2DM and has the potential not only to manage but also to potentially reverse the condition’s progression. However, thorough research and clinical trials are essential to fully understand its safety, efficacy, and long-term impacts [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, it is important to recognize that rabbits may not accurately replicate all pathophysiological processes observed in humans for all diseases. For instance, in humans, type 1 diabetes mellitus (T1DM), a complex autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas, typically involves the production of autoantibodies targeting specific pancreatic antigens, which is not consistently observed in rabbit models ( Bora et al, 2023 ; Jing et al, 2018 ). Moreover, when investigating autoimmune diseases such as systemic lupus erythematosus (SLE), characterized by a complex interplay of genetic and environmental factors, rabbits exhibit a limited genetic predisposition to autoimmune responses compared to certain mouse strains that better model this disease ( Ganor et al, 2014 ; Yang et al, 2009 ).…”
Section: Future Perspectives On Genome-edited Rabbit Modelsmentioning
confidence: 99%